Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)

  • End date
    Apr 27, 2022
  • participants needed
  • sponsor
    Kirby Institute
Updated on 2 August 2020
Mark Polizzotto, MD
Primary Contact
Royal North Shore Hospital (5.0 mi away) Contact
+10 other location
immunosuppressive agents
coronavirus infection


CORIA is an observational cohort study of immunosuppressed populations who test positive for COVID-19. This includes people living with HIV, cancer, acquired immunodeficiency associated with other immunosuppressive therapy, primary immunodeficiency and recipients of a solid organ transplant. Participants will have routine clinical data collected with optional baseline collection and storage of a blood sample for storage . The study will be conducted in up to 30 sites within Australia.

Clinical Study IdentifierNCT04354818
SponsorKirby Institute
Last Modified on2 August 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.


Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 18 yrs?
Gender: Male or Female
Do you have any of these conditions: Cancer (Pediatric) or Covid-19 or Cancer/Tumors or *COVID-19 or Primary Immune Deficiency Disorder or Cancer or Immunosuppression Disorders or Ewing's...?
Presenting (in person or via telemedicine) for evaluation because they
Have clinical symptoms consistent with for COVID-19
Fever ( 37.8 C) on examination OR patient reported fever ( 37.8 C) or feverishness (felt febrile but did not take temperature) OR any of, cough, sore throat, shortness of breath, rhinorrhoea, headache, chills, generalise myalgia, malaise, fatigue, confusion, diarrhea, nausea or vomiting
Have been contacted because they have been identified as a contact to a confirmed case
Have been contacted and told they tested positive for COVID-19
Have one of the following conditions affecting immune function
Known or suspected primary immunodeficiency, defined as a predisposition to infection associated with an apparent or presumed deficit of immune function
On immunosuppressive therapy
Treatment with immune checkpoint inhibitors within 36 months of enrolment date
HIV infection
Diagnosis of cancer within 36 months of enrolment date, excluding superficial basal cell and squamous cell carcinomas
Solid organ transplantation
For optional biobanking only, ability to provide informed consent

Exclusion Criteria

Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer


user name

Annotated by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No made yet